Skip to main content

Table 3 Baseline echocardiographic characteristics

From: Impact of percutaneous ventricular septal defect closure on left ventricular remodeling and function

Measurements   Baseline [median (IQR)]
LVEDD (mm)   40 (34–42)
LVESD (mm)   24 (22–28)
LVEDV (ml)   41(32–50.75)
LVESV (ml)   25 (18–28)
LV mass (gm)   49.5 (37.5–65)
LVEDD/BSA(mm/m2)   46.51(45.45–52.56)
LVESD/BSA(mm/m2)   31.69 (27.91–35.82)
LVEDV/BSA(ml/m2)   52.56 (47.14–58.54)
LVESV/BSA(ml/m2)   31.7 (25.58–34.69)
LV mass/BSA (gm/m2)   62.4(55.2–78.85)
LVEDD Z-score   1.2 (0.0175–1.76)
LVESD Z-score   1.7 (0.59–2.49)
EF (%)   65 (60–69)
VSD-AV distance   5 (4–6.75)
VSD size LV (mm)   10 (6–13)
VSD size RV (mm)   6 (3.3–6.5)
Aneurysmal tissue [no (%)] Incomplete 10 (58.8%)
Complete 4 (23.6%)
No 3 (17.6%)
Gradient across defect (mmHg)   85 (75–93)
  1. AV: Aortic valve, BSA: body surface area, EF: ejection fraction, LA: left atrium, LV: left ventricular, LVEDD: left ventricular end diastolic dimension, LVESD: left ventricular end systolic dimension, LVEDV: left ventricular end diastolic volume, LVESV: left ventricular end systolic volume, RV: right ventricle, VSD: ventricular septal defect